BROADCASTS.com

The OPTIMA trial took place at 7 locations in 4 provinces across Canada and evaluated two opioid agonist treatment models of care:

Methadone and Buprenorphine/Naloxone (Suboxone).

When the idea for OPTIMA began, Methadone was the standard of care for people who used opioids.

Suboxone was also available but not as frequently prescribed.

Physicians wanted to be able to provide Suboxone based on the needs of the client and wanted to be able to do this without having the patient come into the pharmacy all the time to get it

They called it “flexible take-home dosing”

Join us this week for a conversation with Principle Investigator, Didier Jutras-Aswad with the CRCHUM Research Centre in Montreal, Quebec, to learn about what they found, and our opinion on how these findings may affect people who are on Opioid Agonist Therapy.

You won't want to miss this one friends, as we push to the front line of research on this special live edition,

of Hard Knox Talks.

Buckle up!

We've got fresh merch and it's amazing! Pick yours up HERE

Are you getting something from our content? Tap here and buy us a coffee to say thanks and help us keep this train on the tracks!

Check us out on YouTube:
https://www.youtube.com/@hardknoxtalks

Stronger Together Canada Peer Led Support Groups by Moms Stop the Harm
Are you struggling with the substance use of a loved one? Go to
https://www.holdinghopecanada.org/

Have you tragically lost someone to drug related harms? Visit
https://www.healingheartscanada.org/

Prairie Sky Recovery Centre
https://www.prairieskyrecovery.ca/


Info on the Graduate Certificate Program in Substance Use Health and Wellbeing here https://grad.usask.ca/programs/substance-use-health-and-wellbeing.php#Program

The Elizabeth Fry Society of Saskatchewan
https://elizabethfrysask.org/